Lindig, Tobias
Bender, Benjamin
Bürkle, Eva
Kumar, Vinod
Ernemann, Ulrike
Schöls, Ludger
Rattay, Tim W.
Funding for this research was provided by:
Seventh Framework Programme (n° 2012-305121)
Integrated European –omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases
Forum Ge(h)n mit HSP and the Förderverein für HSP-Forschung e.V.
Clinician Scientist Program Grant (#386-0-0)
Universitätsklinikum Tübingen
Article History
Received: 27 June 2022
Accepted: 30 November 2022
First Online: 21 December 2022
Competing interests
: EB, LS, TWR and VK declare that they have no competing interests; BB is co-founder and share-holder of AIRAmed and has received consultancy fees from Medtronic; TL is co-founder, CEO and share-holder of AIRAmed, he has received grants from the Alzheimer Forschung Initiative e.V., travel grants from Bayer and presentation fees from Roche; UE is co-founder and share-holder of AIRAmed.